Inventor · disambiguated record
Neil H. Squires
Also filed as: SQUIRES NEIL · SQUIRES NEIL H · SQUIRES NEIL HOWARD
22 granted patents·17 pending applications·166 citations·filing 2012–2025
95Inventor score
Top patents by PatentIndex Score
39 records- 0197US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0297US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0396US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0496US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 0596US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0696US8877733B21′-substituted pyrimidine N-nucleoside analogs for antiviral treatmentCHO AESOP·Filed 2012·Granted Nov 4, 2014·55 cites·30 claims
- 0795US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 0893US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 0992US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 1092US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 1191US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 1291US10577352B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Granted Mar 3, 2020·10 cites·20 claims
- 1391US10059695B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Aug 28, 2018·12 cites·28 claims
- 1487US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 1587US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1685US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1785US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1883US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1982US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 2080US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 2178US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2277US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 2373US2024262795A1Pyrazine compounds as inhibitors of flt3BIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 2471US11945785B2Pyrazine compounds as inhibitors of FLT3BIOMEA FUSION INC·Filed 2022·Granted Apr 2, 2024·0 cites·28 claims
- 2570US2021251957A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2669US2019248807A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2766US11718637B2Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the sameGILEAD SCIENCES INC·Filed 2021·Granted Aug 8, 2023·0 cites·34 claims
- 2866US2024226130A14'-thionucleoside analogues and their pharmaceutical useGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2966US2018237455A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3062US2025312335A1Flt combination therapy for cancer and compositions thereforBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 3162US2025353854A1Fused pyrimidine compounds as inhibitors of meninBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 3261US2017008905A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3360US2024409558A1Irreversible inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3459US2025066386A1Inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3559US2025304572A1Heterocyclic glp-1r agonistsBIOMEA FUSION INC·Filed 2025·Application pending·0 cites
- 3658US12110305B2Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical useGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·45 claims
- 3758US2025136558A1Pyrazine compounds as irreversible inhibitors of flt3BIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3848US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3947US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Neil H. Squires files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →